Highly sensitive C-reactive protein in metabolic syndrome

Journal, Indian Academy of Clinical Medicine

Volumn 14, Issue 3-4, 2013, Pages 230-234

  Vidyasagar, Sudha ^a   Abdul Razak, U K ^a   Prashanth, C K ^a   Muralidhar Varma, D ^a   Bairy, K L ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

hs CRP; India; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CHRONIC INFLAMMATION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROSPECTIVE STUDY; SATISFACTION; WAIST CIRCUMFERENCE;

EID: 84885365115     PISSN: 09723560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Reaven, GM. Banting lecture. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Alexander CM, Landsman PB, Teutsch SM et al. NCEP defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-4.
3. Zimmet P, Alberti K, Shaw J. Global and social implications of the diabetes epidemic. Nature 2001; 414: 782-7.
4. Pepys, MB, Hirschfield, GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-12.
5. Fröhlich M, Imhof A, Berg G. Association between C reactive protein and features of the metabolic syndrome. Diabetes Care 2000; 23: 1835-9.
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
7. Alberti, KG, Zimmet, P, Shaw, J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-62.
8. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
9. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC VII Report 2003; 289: 2560-71.
10. Eda S, Kaufmann J, Molwitz M et al. Development of a new micro particle-enhanced turbidometric assay for C-reactive protein with superior features in sensitivity and dynamic range. J Clin Lab Anal 1998; 12: 137-44.
11. Bo S, Gentile L, Ciccone G et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev 2005; 21: 515-24.
12. Florez K, Florez SC, Mendez A et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract 2006; 71: 92-100.
13. Ramachandran A, Snehalatha C, Satyavani K et al. Metabolic syndrome in urban Asian Indians adults: a population study using modified ATP III criteria. Diab Res Clin Pract 2003; 60: 199-204.
14. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-9.
15. Ridker PM, Buring JE, Cook NR et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391-7.
16. Rutter MK, Meigs JB, Sullivan LM et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004;110: 380-5.
17. Ridker, PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-9.
18. Hunt KJ, Resendez RG, Williams K et al. NCEP vs WHO metabolic syndrome in relation to all-cause Cardiovascular mortality in the San Antonio Heart Study(SAHS). Circulation 2004;110: 1251-7.
19. Park YW, Zhu S, Palaniappan L et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-36.
20. Gupta R, Deedwania PC, Gupta A et al. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004; 97(2): 257-61.
21. Lim S, Lee HK, Park KC et al. C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population: CRP as risk factor of metabolic syndrome. Diab Res Clin Pract 2005; 70: 126-33.
22. Pitsovas C. Diet, exercise and CRP levels in people with abdominal obesity: the ATTICA epidemiological study. Angiology 2007; 58: 225-33.
23. Miller WM, Memon I, Nori-Janosz KE et al. hs-CRP in the morbidly obese: A predictor of conventional cardiovascular risk factors? Proceedings of 46th annual conference on cardiovascular disease epidemiology and prevention. Circulation 2006; 113: E351.
24. Blake GJ, Rifai N, Buring JE et al. Blood pressure, CRP and risk of future cardiovascular events. Circulation 2003; 108: 2993-9.
25. Picardi A, Valorani MG, Vespasiani Gentilucci U et al. Raised CRP levels in patients with recent onset type 1 diabetes. Diabetes Metab Res Rev 2007; 23: 211-4.
26. Schillaci G, Pirro M. C-reactive protein in hypertension: clinical significance and predictive value. Nutr Metab Cardiovasc Dis 2006; 16: 500-8.
27. Doi Y, Kiyohara Y, Kubo M et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population-The Hisayama Study. Diabetes Care 2005; 28: 2497-500.
28. Festa A, D'Agostino R Jr, Howard G et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-7.
29. Steven M. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006; 97(Suppl): 3A-11A.